美国 · SEC FORM 4
ARDELYX, INC.
ARDX · Nasdaq · CIK 0001437402 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
57 同一窗口内观察到的 Form 4 交易行
44 sales · 13 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 9 additional owner(s) remain in Form 4 申报证据.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-02-20 · MOTT DAVID M.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -13.5%
- 3M
- -39.4%
- 6M
- -46.6%
- 12M
- -37.3%
波动率与流动性
- 波动率
- 65.4%
- Beta
- 0.68
- 平均每日成交额
- USD 13.3M
估值
- 市值
- USD 841.7M
- P/E
- —
基本面
- 利润率
- -15.2%
- ROE
- -37.1%
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-10-07 · 价格来源：OpenBB/yfinance · 来自 SEC 申报文件：利润率, ROE · 财年截止日：2025-12-31 · 来自 Yahoo Finance：市值 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 27,676,626
- 上期报告
- 25,602,541
- 日均成交量
- 4,193,543
- 回补天数
- 6.6
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-02-20 | MOTT DAVID M | 买入 (P) | Common Stock | 333,333 | USD 5.84 | USD 1,946,665 | SEC 申报 ↗ |
| 2025-06-16 | MOTT DAVID M | 买入 (P) | Common Stock | 200,000 | USD 3.63 | USD 726,000 | SEC 申报 ↗ |
| 2025-06-09 | MOTT DAVID M | 买入 (P) | Common Stock | 200,000 | USD 3.69 | USD 738,000 | SEC 申报 ↗ |
| 2025-05-15 | MOTT DAVID M | 买入 (P) | Common Stock | 100,000 | USD 3.29 | USD 329,000 | SEC 申报 ↗ |
| 2025-05-02 | MOTT DAVID M | 买入 (P) | Common Stock | 381,377 | USD 4.22 | USD 1,609,411 | SEC 申报 ↗ |
| 2025-02-24 | MOTT DAVID M | 买入 (P) | Common Stock | 77,729 | USD 5.00 | USD 388,645 | SEC 申报 ↗ |
| 2025-01-21 | MOTT DAVID M | 买入 (P) | Common Stock | 199,000 | USD 4.99 | USD 993,010 | SEC 申报 ↗ |
| 2024-12-19 | MOTT DAVID M | 买入 (P) | Common Stock | 213,300 | USD 4.67 | USD 996,111 | SEC 申报 ↗ |
| 2024-11-13 | MOTT DAVID M | 买入 (P) | Common Stock | 215,868 | USD 4.62 | USD 997,310 | SEC 申报 ↗ |
| 2022-11-17 | MOTT DAVID M | 买入 (P) | Common Stock | 567,000 | USD 1.76 | USD 997,920 | SEC 申报 ↗ |
| 2022-08-31 | Williams Laura A | 买入 (P) | Common Stock | 3,000 | USD 0.62 | USD 1,860 | SEC 申报 ↗ |
| 2022-08-31 | Rosenbaum David P. | 买入 (P) | Common Stock | 3,000 | USD 0.62 | USD 1,860 | SEC 申报 ↗ |
| 2022-08-31 | Renz Justin A | 买入 (P) | Common Stock | 3,000 | USD 0.62 | USD 1,860 | SEC 申报 ↗ |
| 2022-08-31 | RAAB MICHAEL | 买入 (P) | Common Stock | 3,000 | USD 0.62 | USD 1,860 | SEC 申报 ↗ |
| 2022-08-31 | GRAMMER ELIZABETH A | 买入 (P) | Common Stock | 3,000 | USD 0.62 | USD 1,860 | SEC 申报 ↗ |
Form 4 申报证据
103 transaction lines in the latest 365-day window; 591 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-21 | Williams Laura A | 卖出 (S) | Common Stock | 10,739 | USD 3.86 | USD 41,453 | SEC 申报 ↗ |
| 2026-08-21 | Reilly Joseph James | 卖出 (S) | Common Stock | 3,982 | USD 3.86 | USD 15,371 | SEC 申报 ↗ |
| 2026-08-21 | RAAB MICHAEL | 卖出 (S) | Common Stock | 58,574 | USD 3.86 | USD 226,096 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-21 | Williams Laura A | 卖出 (S) | Common Stock | 10,739 | USD 3.86 | USD 41,453 | SEC 申报 ↗ |
| 2026-08-21 | Reilly Joseph James | 卖出 (S) | Common Stock | 3,982 | USD 3.86 | USD 15,371 | SEC 申报 ↗ |
| 2026-08-21 | RAAB MICHAEL | 卖出 (S) | Common Stock | 58,574 | USD 3.86 | USD 226,096 | SEC 申报 ↗ |
| 2026-08-21 | Kelliher Mike | 卖出 (S) | Common Stock | 7,758 | USD 3.86 | USD 29,946 | SEC 申报 ↗ |
| 2026-08-21 | Hohenleitner Susan | 卖出 (S) | Common Stock | 1,558 | USD 3.86 | USD 6,014 | SEC 申报 ↗ |
| 2026-08-21 | Foster Eric Duane | 卖出 (S) | Common Stock | 8,562 | USD 3.86 | USD 33,049 | SEC 申报 ↗ |
| 2026-08-21 | Brady James Parker | 卖出 (S) | Common Stock | 15,136 | USD 3.86 | USD 58,425 | SEC 申报 ↗ |
| 2026-08-21 | Bishop John E | 卖出 (S) | Common Stock | 19,750 | USD 3.86 | USD 76,235 | SEC 申报 ↗ |
| 2026-07-15 | RAAB MICHAEL | 卖出 (S) | Common Stock | 41,668 | USD 5.06 | USD 210,840 | SEC 申报 ↗ |
| 2026-07-15 | RAAB MICHAEL | 期权行权／转换 (M) | Common Stock | 20,834 | USD 0.99 | USD 20,626 | SEC 申报 ↗ |
| 2026-06-18 | Williams Laura A | 卖出 (S) | Common Stock | 81,898 | USD 5.99 | USD 490,569 | SEC 申报 ↗ |
| 2026-06-18 | Williams Laura A | 期权行权／转换 (M) | Common Stock | 31,000 | USD 0.99 | USD 30,690 | SEC 申报 ↗ |
| 2026-06-16 | Rodgers Richard J | 奖励／授予 (A) | Common Stock | 26,455 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-16 | Parsey Merdad | 奖励／授予 (A) | Common Stock | 26,455 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-16 | MOTT DAVID M | 奖励／授予 (A) | Common Stock | 46,737 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-16 | Cadoret-Manier Onaiza | 奖励／授予 (A) | Common Stock | 26,455 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-16 | Bhanji Muna | 奖励／授予 (A) | Common Stock | 26,455 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-16 | Bertrand William C JR | 奖励／授予 (A) | Common Stock | 38,800 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-16 | Bazemore Robert B | 奖励／授予 (A) | Common Stock | 26,455 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-15 | RAAB MICHAEL | 卖出 (S) | Common Stock | 41,666 | USD 5.67 | USD 236,246 | SEC 申报 ↗ |
| 2026-06-15 | RAAB MICHAEL | 期权行权／转换 (M) | Common Stock | 20,833 | USD 0.99 | USD 20,625 | SEC 申报 ↗ |
| 2026-05-21 | Williams Laura A | 卖出 (S) | Common Stock | 6,989 | USD 6.27 | USD 43,821 | SEC 申报 ↗ |
| 2026-05-21 | Reilly Joseph James | 卖出 (S) | Common Stock | 3,719 | USD 6.27 | USD 23,318 | SEC 申报 ↗ |
| 2026-05-21 | RAAB MICHAEL | 卖出 (S) | Common Stock | 54,748 | USD 6.27 | USD 343,270 | SEC 申报 ↗ |
| 2026-05-21 | Kelliher Mike | 卖出 (S) | Common Stock | 7,248 | USD 6.27 | USD 45,445 | SEC 申报 ↗ |
| 2026-05-21 | Hohenleitner Susan | 卖出 (S) | Common Stock | 1,455 | USD 6.27 | USD 9,123 | SEC 申报 ↗ |
| 2026-05-21 | Foster Eric Duane | 卖出 (S) | Common Stock | 7,998 | USD 6.27 | USD 50,147 | SEC 申报 ↗ |
| 2026-05-21 | Brady James Parker | 卖出 (S) | Common Stock | 1,846 | USD 6.27 | USD 11,574 | SEC 申报 ↗ |
| 2026-05-21 | Bishop John E | 卖出 (S) | Common Stock | 2,306 | USD 6.27 | USD 14,459 | SEC 申报 ↗ |
| 2026-05-15 | RAAB MICHAEL | 卖出 (S) | Common Stock | 41,666 | USD 6.28 | USD 261,662 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ARDX |
| CIK | 0001437402 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 591 transaction lines from 2020-02-05 to 2026-08-21 20 P purchase lines · 386 S sale lines · 185 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.